H. Langemann

1.0k total citations
37 papers, 675 citations indexed

About

H. Langemann is a scholar working on Cellular and Molecular Neuroscience, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, H. Langemann has authored 37 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Epidemiology. Recurrent topics in H. Langemann's work include Neuroscience and Neuropharmacology Research (8 papers), Neuroendocrine Tumor Research Advances (6 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). H. Langemann is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Neuroendocrine Tumor Research Advances (6 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). H. Langemann collaborates with scholars based in Switzerland, United States and United Kingdom. H. Langemann's co-authors include W. Lichtensteiger, Peter G. Waser, Margret Schlumpf, Franz Hefti, Charles J. Kensler, Chr. Hedinger, Marilise Escobar Bürger, C Hedinger, Paul J. Keller and J. H. Burn and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Physiology and Brain Research.

In The Last Decade

H. Langemann

36 papers receiving 593 citations

Peers

H. Langemann
Paul R. Draskóczy United States
P Joanny France
H.C. Stanton United States
Ph. De Witte Belgium
T.A. Hare United States
L. Eroğlu Türkiye
H. Langemann
Citations per year, relative to H. Langemann H. Langemann (= 1×) peers Andrée G. Roberge

Countries citing papers authored by H. Langemann

Since Specialization
Citations

This map shows the geographic impact of H. Langemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Langemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Langemann more than expected).

Fields of papers citing papers by H. Langemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Langemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Langemann. The network helps show where H. Langemann may publish in the future.

Co-authorship network of co-authors of H. Langemann

This figure shows the co-authorship network connecting the top 25 collaborators of H. Langemann. A scholar is included among the top collaborators of H. Langemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Langemann. H. Langemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lichtensteiger, W., et al.. (1975). Response of nigral dopamine neurons to acute and prolonged morphine treatment. Naunyn-Schmiedeberg s Archives of Pharmacology. 286(4). 353–369. 16 indexed citations
2.
Schlumpf, Margret, et al.. (1974). Standardized excision of small areas of rat and mouse brain with topographical control. Biochemical Pharmacology. 23(17). 2447–2449. 25 indexed citations
3.
Lichtensteiger, W., et al.. (1971). EFFECT OF MORPHINE ON THE CATECHOLAMINE CONTENT OF MIDBRAIN NERVE CELL GROUPS IN RAT AND MOUSE. Journal of Pharmacology and Experimental Therapeutics. 179(2). 259–267. 14 indexed citations
4.
Lichtensteiger, W. & H. Langemann. (1969). Microfluorimetric Investigations of Catecholamine-Containing Neurons. Progress in brain research. 31. 87–93. 1 indexed citations
5.
Lichtensteiger, W., et al.. (1966). [Uptake of 5-hydroxytryptamine and 5-hydroxytrytophan in normally catecholamine-containing neurons of the central nervous system].. PubMed. 68. C101–2. 2 indexed citations
6.
Lichtensteiger, W. & H. Langemann. (1966). UPTAKE OF EXOGENOUS CATECHOLAMINES BY MONOAMINE-CONTAINING NEURONS OF THE CENTRAL NERVOUS SYSTEM: UPTAKE OF CATECHOLAMINES BY ARCUATO-INFUNDIBULAR NEURONS. Journal of Pharmacology and Experimental Therapeutics. 151(3). 400–408. 71 indexed citations
7.
Langemann, H., et al.. (1962). Decarboxylierung von Dopa durch Herzmuskel von Meerschweinchen. Journal of Molecular Medicine. 40(17). 911–913. 3 indexed citations
8.
Langemann, H., et al.. (1962). [Amino acid decarboxylase in pheochromocytoma and carcinoid tissue].. PubMed. 92. 1621–3. 3 indexed citations
9.
Langemann, H. & H. Ackermann. (1961). [On the activity of amino acid decarboxylases in the brain of man].. PubMed. 19. 399–406. 2 indexed citations
10.
Langemann, H.. (1959). [Noradrenaline and its significance in pharmacology].. PubMed. 89. 1297–301. 1 indexed citations
11.
Langemann, H.. (1957). Bestimmungen von Fermenten und ihren Substraten und Reaktionsprodukten in Zellfraktionen von D�nn-darmkarzinoid-Metastase und Phaeochromozytom. Journal of Neural Transmission. 16(1-4). 333–335. 2 indexed citations
12.
Giger, K., et al.. (1957). [Changes in adrenalin and noradrenalin concentrations in human blood plasma under the effects of phentolamine (regitine)].. PubMed. 15(1). 8–13. 2 indexed citations
13.
Bürger, Marilise Escobar & H. Langemann. (1956). Bestimmungen von Adrenalin und Noradrenalin sowie von Decarboxylase-und Aminoxydase-Aktivit�ten in Zellfraktionen von Ph�ochromocytomen. Journal of Molecular Medicine. 34(35-36). 941–944. 11 indexed citations
14.
Langemann, H.. (1955). [Oxytryptamin (Serotonin) as a new hormone; with a special reference to its relation to the syndrome of metastatic carcinoids].. PubMed. 85(40). 957–61. 11 indexed citations
15.
Hegglin, R & H. Langemann. (1955). [Clinical manifestations and detection of 5-hydroxy-indolacetic acid and 5-hydroxy-tryptamine in metastasizing carcinoid of the small intestine].. PubMed. 22(4-5). 463–9. 3 indexed citations
16.
Kägi, Jeremias H.R. & H. Langemann. (1955). For Pheochromocytoma Diagnostics.. PubMed. 85(17). 402–4. 1 indexed citations
17.
Hedinger, C & H. Langemann. (1955). [Kidney damage with cortical necrosis in rats under treatment with 5-oxytryptamin; additional experimental contribution to the question of endocrine activity of carcinoids].. PubMed. 85(22). 541–4. 10 indexed citations
18.
Kensler, Charles J., H. Langemann, & Charles L. Zirkle. (1954). THE CHOLINERGIC ACTIVITY OF TETRAKIS-(DIMETHYLAMINO-METHYL)-METHANE TETRAMETHOBROMIDE. Journal of Pharmacology and Experimental Therapeutics. 110(2). 127–134. 2 indexed citations
19.
Langemann, H., Thomas Brody, & James A. Bain. (1953). IN VITRO EFFECTS OF OUABAIN ON SLICES AND MITOCHONDRIAL PREPARATIONS FROM HEART AND BRAIN. Journal of Pharmacology and Experimental Therapeutics. 108(3). 274–280. 9 indexed citations
20.
Burn, J. H., et al.. (1951). Noradrenaline in whale suprarenal medulla. The Journal of Physiology. 113(1). 123–128. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026